Am J Perinatol 2020; 37(S 02): S89-S100
DOI: 10.1055/s-0040-1716966
Selected Abstracts
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Factor Selection for the Chronic Lung Disease of Prematurity Severity Scale

R. Steinhorn
1   Hospital Specialty and Critical Care, Children's National Health System, Washington, DC
,
M. Hallman
2   Department of Paediatrics, University of Oulu and Oulu University Hospital, Oulu, Finland
,
R. Ward
3   Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah
,
E. Schwartz
4   Patient Centered Outcomes, ICON, Gaithersburg, Maryland
,
M. Vanya
5   Patient Centered Outcomes, ICON, South San Francisco, California
,
E. Janssen
4   Patient Centered Outcomes, ICON, Gaithersburg, Maryland
,
L. Han
6   Global Clinical Development, Takeda, Cambridge, Massachusetts
,
A. Mangili
7   Global Clinical Development, Takeda, Zurich, Switzerland
,
S. Sarda
8   Global Evidence and Outcomes, Takeda, Lexington, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
08 September 2020 (online)

 
 

    Introduction Chronic lung disease of prematurity (CLDP) is a frequent complication following extremely preterm (EP) birth. We developed the chronic lung disease of prematurity severity scale (CLDPSS) for use in clinical trials with EP infants (<28 weeks’ gestational age), for the period between discharge to home from the neonatal intensive care unit and 12 months corrected age (CA). Rounds 1 and 2 of an online survey utilizing Delphi methodology were previously conducted to identify factors in determining CLDP severity, for inclusion in the CLDPSS. Here, we report Round 3 findings.

    Materials and Methods In Round 2, clinicians had rated the importance of respiratory-related factors used to evaluate the severity of CLDP, from 0 (not at all important) to 10 (very important), for the period between discharge home from the neonatal intensive care unit and 12 months CA. Clinicians also ranked the relative importance of these factors in determining severity. Thirteen factors were considered ([Table A002]). In Round 3, clinicians were presented with aggregate results from Round 2 and could revise their previous responses. The relative importance of factors was explored through a set of 16 single-profile tasks (i.e., hypothetical patient profiles with varying CLDP severity levels).

    Results The Round 3 survey was completed by 88 clinicians experienced in treating prematurity-related lung diseases such as CLDP (pediatric pulmonologists, n = 50; pediatricians, n = 19; neonatologists, n = 19). Participants resided in 11 countries across North America, Europe, Asia, and South America. Round 3 findings indicated that the four most important factors in determining the severity of CLDP were home mechanical ventilation (MV, mean absolute importance rating = 8.89), supplemental oxygen ≥2 L/min (8.49), rehospitalizations (7.65), and supplemental oxygen <2 L/min (7.56). The same four factors were ranked most important relative to the others. Single-profile tasks indicated that supplemental oxygen had the largest influence on the predicted probability that a patient profile would be classified as asymptomatic/minimal, mild, moderate or severe lung disease.

    Conclusion The most important factors for clinicians in assessing CLDP severity during infancy were home MV, supplemental oxygen ≥2 L/min, and respiratory-related rehospitalizations. Single-profile tasks highlighted the importance of oxygen-related factors.

    Table A002

    Factors

    Home mechanical ventilation, including BiPAP and NIPPV

    Supplemental oxygen via nasal cannula at ≥2 L/min, including CPAP

    Supplemental oxygen via nasal cannula at ≥2 L/min

    Respiratory-related rehospitalization after NICU discharge

    Respiratory-related ED visits without hospitalization

    Daily administration of bronchodilator

    Daily administration of inhaled corticosteroid

    Daily administration of diuretic

    Daily administration of pulmonary vasodilator

    Intermittent administration of bronchodilator

    Intermittent administration of inhaled corticosteroid

    Intermittent administration of systemic corticosteroid

    Intermittent administration of diuretic

    Abbreviations: BiPAP, bi-level positive airway pressure; CPAP, continuous positive airway pressure; ED, emergency department; NICU, neonatal intensive care unit; NIPPV, nasal intermittent p positive pressure ventilation for pulmonary vasodilators.


    Daily = everyday for other medications, daily ≥3 days/week.


    Conflict of Interest

    None declared.


    #

    No conflict of interest has been declared by the author(s).